Brief: Astellas And Poseida Therapeutics Enter Collab And License Agreement To Develop Novel Allogeneic Cell Therapies
01/05/2024 14:18
May 1 (Reuters) - Poseida Therapeutics Inc PSTX.O :
* ASTELLAS AND POSEIDA THERAPEUTICS ENTER INTO RESEARCH
COLLABORATION AND LICENSE AGREEMENT TO DEVELOP NOVEL ALLOGENEIC
CELL THERAPIES IN ONCOLOGY
* POSEIDA THERAPEUTICS - TO RECEIVE US $50 MILLION UPFRONT
PLUS
POTENTIAL DEVELOPMENT,SALES MILESTONES, CONTINGENCY PAYMENTS OF
UP TO US $550 MILLION IN TOTAL
* POSEIDA THERAPEUTICS INC - IS ELIGIBLE FOR UP TO LOW
DOUBLE
DIGIT TIERED ROYALTIES AS A PERCENTAGE OF NET SALES UNDER DEAL
Source text for Eikon: ID:nPn7N6kZ1a
Further company coverage: PSTX.O
((Reuters.Briefs@thomsonreuters.com;))